vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and Orange County Bancorp, Inc. (OBT). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $33.0M, roughly 1.9× Orange County Bancorp, Inc.). Orange County Bancorp, Inc. runs the higher net margin — 37.6% vs -70.9%, a 108.6% gap on every dollar of revenue. On growth, Orange County Bancorp, Inc. posted the faster year-over-year revenue change (20.6% vs 8.1%). Orange County Bancorp, Inc. produced more free cash flow last quarter ($41.3M vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 14.3%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Orange County Bancorp, Inc. is a Delaware-registered bank holding company operating mainly in New York, U.S. It offers a full range of retail and commercial banking services, including deposit accounts, loans and wealth management solutions, serving individual consumers, small and mid-sized corporate clients in its regional footprint.
CTKB vs OBT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $33.0M |
| Net Profit | $-44.1M | $12.4M |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | 41.4% |
| Net Margin | -70.9% | 37.6% |
| Revenue YoY | 8.1% | 20.6% |
| Net Profit YoY | -557.1% | 73.5% |
| EPS (diluted) | — | $0.94 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $33.0M | ||
| Q3 25 | $52.3M | $33.7M | ||
| Q2 25 | $45.6M | $32.5M | ||
| Q1 25 | $41.5M | $28.0M | ||
| Q4 24 | $57.5M | $27.4M | ||
| Q3 24 | $51.5M | $27.1M | ||
| Q2 24 | $46.6M | $27.9M | ||
| Q1 24 | $44.9M | $25.3M |
| Q4 25 | $-44.1M | $12.4M | ||
| Q3 25 | $-5.5M | $10.0M | ||
| Q2 25 | $-5.6M | $10.5M | ||
| Q1 25 | $-11.4M | $8.7M | ||
| Q4 24 | $9.6M | $7.2M | ||
| Q3 24 | $941.0K | $3.2M | ||
| Q2 24 | $-10.4M | $8.2M | ||
| Q1 24 | $-6.2M | $9.3M |
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
| Q4 25 | -9.0% | 41.4% | ||
| Q3 25 | -17.6% | 38.6% | ||
| Q2 25 | -23.3% | 41.9% | ||
| Q1 25 | -36.1% | 40.3% | ||
| Q4 24 | 5.2% | 32.8% | ||
| Q3 24 | -8.2% | 14.8% | ||
| Q2 24 | -18.3% | 36.6% | ||
| Q1 24 | -23.9% | 45.9% |
| Q4 25 | -70.9% | 37.6% | ||
| Q3 25 | -10.5% | 29.7% | ||
| Q2 25 | -12.2% | 32.2% | ||
| Q1 25 | -27.5% | 31.1% | ||
| Q4 24 | 16.8% | 26.2% | ||
| Q3 24 | 1.8% | 11.8% | ||
| Q2 24 | -22.4% | 29.4% | ||
| Q1 24 | -13.8% | 36.7% |
| Q4 25 | — | $0.94 | ||
| Q3 25 | — | $0.75 | ||
| Q2 25 | — | $0.87 | ||
| Q1 25 | — | $0.77 | ||
| Q4 24 | — | $0.64 | ||
| Q3 24 | — | $0.28 | ||
| Q2 24 | — | $0.73 | ||
| Q1 24 | — | $0.82 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $284.4M |
| Total Assets | $461.5M | $2.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | — | ||
| Q3 25 | $93.3M | — | ||
| Q2 25 | $75.5M | — | ||
| Q1 25 | $95.3M | — | ||
| Q4 24 | $98.7M | — | ||
| Q3 24 | $162.3M | — | ||
| Q2 24 | $177.9M | — | ||
| Q1 24 | $168.8M | — |
| Q4 25 | $341.7M | $284.4M | ||
| Q3 25 | $378.6M | $270.1M | ||
| Q2 25 | $377.6M | $252.6M | ||
| Q1 25 | $379.6M | $201.3M | ||
| Q4 24 | $395.7M | $185.5M | ||
| Q3 24 | $385.5M | $193.1M | ||
| Q2 24 | $389.1M | $177.5M | ||
| Q1 24 | $392.6M | $168.7M |
| Q4 25 | $461.5M | $2.7B | ||
| Q3 25 | $494.9M | $2.6B | ||
| Q2 25 | $493.3M | $2.6B | ||
| Q1 25 | $482.6M | $2.6B | ||
| Q4 24 | $499.5M | $2.5B | ||
| Q3 24 | $491.2M | $2.5B | ||
| Q2 24 | $483.7M | $2.5B | ||
| Q1 24 | $492.1M | $2.5B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $43.8M |
| Free Cash FlowOCF − Capex | $-1.8M | $41.3M |
| FCF MarginFCF / Revenue | -2.9% | 125.1% |
| Capex IntensityCapex / Revenue | 1.6% | 7.6% |
| Cash ConversionOCF / Net Profit | — | 3.53× |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $69.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $43.8M | ||
| Q3 25 | $-3.9M | $30.2M | ||
| Q2 25 | $108.0K | $-5.0M | ||
| Q1 25 | $-125.0K | $4.8M | ||
| Q4 24 | $2.0M | $34.6M | ||
| Q3 24 | $13.2M | $10.2M | ||
| Q2 24 | $6.2M | $9.3M | ||
| Q1 24 | $4.0M | $2.3M |
| Q4 25 | $-1.8M | $41.3M | ||
| Q3 25 | $-4.6M | $29.6M | ||
| Q2 25 | $-1.5M | $-5.7M | ||
| Q1 25 | $-974.0K | $4.3M | ||
| Q4 24 | $1.1M | $32.9M | ||
| Q3 24 | $12.2M | $10.0M | ||
| Q2 24 | $5.2M | $9.2M | ||
| Q1 24 | $3.4M | $2.0M |
| Q4 25 | -2.9% | 125.1% | ||
| Q3 25 | -8.7% | 87.8% | ||
| Q2 25 | -3.2% | -17.5% | ||
| Q1 25 | -2.3% | 15.5% | ||
| Q4 24 | 1.9% | 120.0% | ||
| Q3 24 | 23.7% | 36.7% | ||
| Q2 24 | 11.0% | 32.8% | ||
| Q1 24 | 7.6% | 7.9% |
| Q4 25 | 1.6% | 7.6% | ||
| Q3 25 | 1.3% | 1.8% | ||
| Q2 25 | 3.5% | 2.3% | ||
| Q1 25 | 2.0% | 1.8% | ||
| Q4 24 | 1.6% | 6.3% | ||
| Q3 24 | 2.0% | 1.1% | ||
| Q2 24 | 2.3% | 0.4% | ||
| Q1 24 | 1.3% | 1.0% |
| Q4 25 | — | 3.53× | ||
| Q3 25 | — | 3.01× | ||
| Q2 25 | — | -0.47× | ||
| Q1 25 | — | 0.56× | ||
| Q4 24 | 0.21× | 4.83× | ||
| Q3 24 | 14.05× | 3.19× | ||
| Q2 24 | — | 1.13× | ||
| Q1 24 | — | 0.24× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
OBT
Segment breakdown not available.
